Oramed Pharmaceuticals (ORMP) Net Cash Flow (2010 - 2026)
Oramed Pharmaceuticals (ORMP) posted Net Cash Flow of -$32.8 million for Q1 2026, down 432.02% on a QoQ basis from -$6.2 million in Q4 2025, and down 263.04% year-over-year from $20.1 million in Q1 2025.
Oramed Pharmaceuticals (ORMP) Net Cash Flow (2010 - 2026) Analysis & Trends
Oramed Pharmaceuticals' Net Cash Flow history runs 17 years deep, the most recent figure standing at -$32.8 million for Q1 2026.
- Quarterly Net Cash Flow fell 263.04% year-over-year to -$32.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$60.9 million (down 208.92% YoY) and the FY2025 annual result came in at -$8.4 million, down 118.61% from the prior year.
- Net Cash Flow was -$32.8 million for Q1 2026 at Oramed Pharmaceuticals, down from -$6.2 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $66.2 million in Q2 2024 and bottomed at -$58.4 million in Q2 2025.
- A 5-year average of -$809000.0 and a median of $1.9 million in 2022 frame the typical range for Net Cash Flow.
- Peak annual rise in Net Cash Flow reached 481.58% in 2024, while the deepest fall reached 3263.72% in 2024.
- Oramed Pharmaceuticals' Net Cash Flow stood at $7.4 million in 2022, then sank by 51.46% to $3.6 million in 2023, then jumped by 244.17% to $12.3 million in 2024, then plunged by 150.0% to -$6.2 million in 2025, then slumped by 432.02% to -$32.8 million in 2026.
- Business Quant data shows ORMP's Net Cash Flow at -$32.8 million in Q1 2026, -$6.2 million in Q4 2025, and $36.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 10.56 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 224.46 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 457.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -152.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | Oramed Pharmaceuticals | 170.25 Mn | 170.25 Mn | - | -32.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -32.77 Mn |
| Mar 31, 2026 | -32.77 Mn |
| Dec 31, 2025 | -6.16 Mn |
| Dec 31, 2025 | -6.16 Mn |
| Sep 30, 2025 | 36.38 Mn |
| Sep 30, 2025 | 36.38 Mn |
| Jun 30, 2025 | -58.39 Mn |
| Jun 30, 2025 | -58.39 Mn |
| Mar 31, 2025 | 20.10 Mn |
| Mar 31, 2025 | 20.10 Mn |
| Dec 31, 2024 | 12.32 Mn |
| Dec 31, 2024 | 12.32 Mn |
| Sep 30, 2024 | -42.65 Mn |
| Sep 30, 2024 | -42.65 Mn |
| Jun 30, 2024 | 66.18 Mn |
| Jun 30, 2024 | 66.18 Mn |
| Mar 31, 2024 | 9.52 Mn |
| Mar 31, 2024 | 9.52 Mn |
| Dec 31, 2023 | 3.58 Mn |
| Dec 31, 2023 | 3.58 Mn |